CHAPTER 1. Industry Overview of Bone Marrow Transplantation Market
1.1. Definition and Scope
1.1.1. Definition of Bone Marrow Transplantation
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Bone Marrow Transplantation Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Bone Marrow Transplantation Market By Type
1.2.3. Bone Marrow Transplantation Market By Indications
1.2.4. Bone Marrow Transplantation Market By End-User
1.2.5. Bone Marrow Transplantation Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Bone Marrow Transplantation Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Bone Marrow Transplantation Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Bone Marrow Transplantation Market By Type
4.1. Introduction
4.2. Bone Marrow Transplantation Revenue By Type
4.2.1. Bone Marrow Transplantation Revenue (USD Million) and Forecast, By Type, 2018-2030
4.2.2. Allogeneic Bone Marrow Transplant
4.2.2.1. Allogeneic Bone Marrow Transplant Market Revenue (USD Million) and Growth Rate (%), 2018-2030
4.2.3. Autologous Bone Marrow Transplant
4.2.3.1. Autologous Bone Marrow Transplant Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 5. Bone Marrow Transplantation Market By Indications
5.1. Introduction
5.2. Bone Marrow Transplantation Revenue By Indications
5.2.1. Bone Marrow Transplantation Revenue (USD Million) and Forecast, By Indications, 2018-2030
5.2.2. Hodgkin Lymphoma
5.2.2.1. Hodgkin Lymphoma Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.3. Acute Leukaemia
5.2.3.1. Acute Leukaemia Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.4. Multiple Myelomas
5.2.4.1. Multiple Myelomas Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.5. Solid Tumours
5.2.5.1. Solid Tumours Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.6. Non-Hodgkin Lymphoma
5.2.6.1. Non-Hodgkin Lymphoma Market Revenue (USD Million) and Growth Rate (%), 2018-2030
5.2.7. Others
5.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 6. Bone Marrow Transplantation Market By End-User
6.1. Introduction
6.2. Bone Marrow Transplantation Revenue By End-User
6.2.1. Bone Marrow Transplantation Revenue (USD Million) and Forecast, By End-User, 2018-2030
6.2.2. Hospitals
6.2.2.1. Hospitals Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.3. Multispecialty Clinics
6.2.3.1. Multispecialty Clinics Market Revenue (USD Million) and Growth Rate (%), 2018-2030
6.2.4. Ambulatory Surgical Centre
6.2.4.1. Ambulatory Surgical Centre Market Revenue (USD Million) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Bone Marrow Transplantation Market By Country
7.1. North America Bone Marrow Transplantation Market Overview
7.2. U.S.
7.2.1. U.S. Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
7.2.2. U.S. Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
7.2.3. U.S. Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
7.3. Canada
7.3.1. Canada Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
7.3.2. Canada Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
7.3.3. Canada Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Bone Marrow Transplantation Market By Country
8.1. Europe Bone Marrow Transplantation Market Overview
8.2. U.K.
8.2.1. U.K. Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
8.2.2. U.K. Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
8.2.3. U.K. Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
8.3. Germany
8.3.1. Germany Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
8.3.2. Germany Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
8.3.3. Germany Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
8.4. France
8.4.1. France Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
8.4.2. France Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
8.4.3. France Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
8.5. Spain
8.5.1. Spain Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
8.5.2. Spain Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
8.5.3. Spain Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
8.6.2. Rest of Europe Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
8.6.3. Rest of Europe Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Bone Marrow Transplantation Market By Country
9.1. Asia Pacific Bone Marrow Transplantation Market Overview
9.2. China
9.2.1. China Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
9.2.2. China Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
9.2.3. China Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
9.3. Japan
9.3.1. Japan Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
9.3.2. Japan Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
9.3.3. Japan Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
9.4. India
9.4.1. India Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
9.4.2. India Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
9.4.3. India Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
9.5. Australia
9.5.1. Australia Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
9.5.2. Australia Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
9.5.3. Australia Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
9.6. South Korea
9.6.1. South Korea Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
9.6.2. South Korea Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
9.6.3. South Korea Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
9.7.2. Rest of Asia-Pacific Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
9.7.3. Rest of Asia-Pacific Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Bone Marrow Transplantation Market By Country
10.1. Latin America Bone Marrow Transplantation Market Overview
10.2. Brazil
10.2.1. Brazil Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
10.2.2. Brazil Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
10.2.3. Brazil Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
10.3. Mexico
10.3.1. Mexico Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
10.3.2. Mexico Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
10.3.3. Mexico Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
10.4.2. Rest of Latin America Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
10.4.3. Rest of Latin America Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Bone Marrow Transplantation Market By Country
11.1. Middle East & Africa Bone Marrow Transplantation Market Overview
11.2. GCC
11.2.1. GCC Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
11.2.2. GCC Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
11.2.3. GCC Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
11.3. South Africa
11.3.1. South Africa Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
11.3.2. South Africa Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
11.3.3. South Africa Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Bone Marrow Transplantation Revenue (USD Million) and Forecast By Type, 2018-2030
11.4.2. Rest of Middle East & Africa Bone Marrow Transplantation Revenue (USD Million) and Forecast By Indications, 2018-2030
11.4.3. Rest of Middle East & Africa Bone Marrow Transplantation Revenue (USD Million) and Forecast By End-User, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Bone Marrow Transplantation Market
12.1. Bone Marrow Transplantation Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Bone Marrow Transplantation Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Abbott Laboratories
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Million), 2021
13.1.3.2. Abbott Laboratories 2021 Bone Marrow Transplantation Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Agendia
13.3. Merck Millipore Corporation
13.4. Sanofi
13.5. AllCells LLC
13.6. Diadexus Inc.
13.7. STEMCELL Technologies
13.8. Lonza Group Ltd.
13.9. Conversant Bio
13.10. Qiagen N.V.
The market size of bone marrow transplantation market in 2021 was accounted to be USD 11,108 Million.
The projected CAGR of bone marrow transplantation market during the analysis period of 2022 to 2030 is 5.7%.
The prominent players of the global bone marrow transplantation market are Agendia, Merck Millipore Corporation, Sanofi, AllCells LLC, Diadexus Inc., Abbott, STEMCELL Technologies, Lonza Group Ltd., Conversant Bio, and Qiagen N.V.
North America held the dominating bone marrow transplantation during the analysis period of 2022 to 2030.
Asia-Pacific region exhibited fastest growing CAGR for bone marrow transplantation during the analysis period of 2022 to 2030.
Growing clinical trials for cell therapy, growing prevalence of blood cancer across the world, and increasing number of surgical procedures drives the growth of global bone marrow transplantation market.
Based on type, analogous bone marrow transplant segment is expected to hold the maximum share bone marrow transplantation market.
Customer Satisfaction
Availability - we are always there when you need us
Fortune 50 Companies trust Acumen Research and Consulting
of our reports are exclusive and first in the industry
more data and analysis
reports published till date